Literature DB >> 9698002

Revision of a total hip arthroplasty with a Harris-Galante porous-coated acetabular component inserted without cement. A follow-up note on the results at five to twelve years.

P F Lachiewicz1, E D Poon.   

Abstract

Fifty-seven revision total hip arthroplasties in fifty-six patients were performed with a Harris-Galante porous-coated acetabular component by one surgeon, and the patients were followed prospectively for a mean of seven years (range, five to twelve years). A trochanteric osteotomy was performed in forty hips, and a posterior approach with an extended anterior capsulectomy was used in the other seventeen. The acetabular defect was classified as segmental in seven hips, cavitary in twenty-three, and combined in twenty-one; six hips had no notable defect. A bulk allograft was used in eleven hips, and morseled cancellous-bone allograft or autogenous graft was used in thirty-four hips; twelve hips did not have bone-grafting. Both the femoral and the acetabular component were revised in forty-five hips, and only the acetabular component was revised in twelve. Thirty-nine hips (68 per cent) had a good or excellent clinical result according to the Harris hip score. The acetabular component was well fixed in the fourteen hips that had a fair result and the four hips that had a poor result. The acetabular component was considered to have migrated if there was a change in the angle of the cup of 5 degrees or more or a change in the horizontal or vertical position of the cup of more than three millimeters. Despite varying degrees of bone loss, no acetabular component had radiographic evidence of loosening at the latest follow-up examination. No component was revised and no revisions were scheduled. One hip was debrided for a late metastatic infection, but the component was well fixed and was not revised. There were no complications related to the use of screws for fixation. These mid-term results confirm the early success of acetabular revisions performed with fixation of a titanium fiber-metal-coated hemispherical component with multiple screws and no cement.

Entities:  

Mesh:

Year:  1998        PMID: 9698002     DOI: 10.2106/00004623-199807000-00006

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  Revision hip arthroplasty using impacted cancellous bone and cement: a long-term follow-up study.

Authors:  Gowthaman Arumugam; Shashi Kumar Nanjayan; Conal Quah; Philip Wraighte; Peter Howard
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-23

2.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

Review 3.  Cementless acetabular revision: past, present, and future. Revision total hip arthroplasty: the acetabular side using cementless implants.

Authors:  Luis Pulido; Sridhar R Rachala; Miguel E Cabanela
Journal:  Int Orthop       Date:  2011-01-14       Impact factor: 3.075

4.  Method of fixation does not influence the overall risk of rerevision in first-time cup revisions.

Authors:  Maziar Mohaddes; Göran Garellick; Johan Kärrholm
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

5.  Results of the cementless Plasmacup in revision total hip arthroplasty: a retrospective study of 72 cases with an average follow-up of eight years.

Authors:  Stefan Lakemeier; Guenter Aurand; Nina Timmesfeld; Thomas J Heyse; Susanne Fuchs-Winkelmann; Markus D Schofer
Journal:  BMC Musculoskelet Disord       Date:  2010-05-27       Impact factor: 2.362

6.  Short-term survival of the trabecular metal cup is similar to that of standard cups used in acetabular revision surgery.

Authors:  Maziar Mohaddes; Ola Rolfson; Johan Kärrholm
Journal:  Acta Orthop       Date:  2014-11-17       Impact factor: 3.717

7.  Mid-Term Follow-Up of Acetabular Revision Arthroplasty Using Jumbo Cups.

Authors:  Ji Zhang; Yong Huang; Baochun Zhou; Yixin Zhou
Journal:  Orthop Surg       Date:  2019-09-24       Impact factor: 2.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.